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Pluripotent stem cells self-renew indefinitely and
possess characteristic protein-protein networks
that remodel during differentiation. How this occurs
is poorly understood. Using quantitative mass spec-
trometry, we analyzed the (phospho)proteome of
human embryonic stem cells (hESCs) during differen-
tiation induced by bone morphogenetic protein (BMP)
and removal of hESC growth factors. Of 5222 proteins
identified, 1399 were phosphorylated on 3067 resi-
dues. Approximately 50% of these phosphosites
were regulated within 1 hr of differentiation induction,
revealing a complex interplay of phosphorylation
networks spanning different signaling pathways and
kinase activities. Among the phosphorylated proteins
was the pluripotency-associated protein SOX2,
which was SUMOylated as a result of phosphoryla-
tion. Using the data to predict kinase-substrate
relationships, we reconstructed the hESC kinome;
CDK1/2 emerged as central in controlling self-
renewal and lineage specification. The findings pro-
vide new insights into how hESCs exit the pluripotent
state and present the hESC (phospho)proteome
resource as a complement to existing pluripotency
network databases.
INTRODUCTION
All future applications of pluripotent cells depend on exquisite
control of their developmental fate. An essential first step for
differentiation is exit from the pluripotent state, but exactly how
this is regulated is unclear. Recent evidence for a core transcrip-
tional machinery regulating pluripotency (Muller et al., 2008) has
indicated the most important pathways for functional interroga-214 Cell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc.tion, but information on the activation state of component
proteins is largely unknown. Here, we analyzed the proteome
and phosphoproteome of human embryonic stem cells (hESCs),
prototype pluripotent cells, for this purpose and compared this
profile globally with that immediately after induction of differenti-
ation.
ESCs are derived from preimplantation embryos, self-renew
indefinitely, and can undergo multilineage differentiation (Thom-
son et al., 1998). Although mouse ESCs (mESCs) and hESCs
have a similar core transcriptional regulatory network involving
OCT4 (Niwa et al., 2000), SOX2 (Avilion et al., 2003; Yuan
et al., 1995), and NANOG (Mitsui et al., 2003), they differ in their
growth requirements. BMP and leukemia inhibitory factor
sustain self-renewal of mESCs (Ying et al., 2003), but hESCs
require basic fibroblast growth factor (bFGF) and transforming
growth factor b (TGF-b)/Activin A signaling (Vallier et al., 2005;
Xu et al., 2005). In fact, BMPs rapidly induce differentiation of
hESCs (Pera et al., 2004; Xu et al., 2002). In all pluripotent cells,
however, the pluripotent genes OCT4, SOX2, and NANOG
collaborate by co-occupying the promoters of many genes,
including their own, thereby promoting expression of ESC-asso-
ciated genes and repressing lineage specification genes (Boyer
et al., 2005; Loh et al., 2006).
Recent studies have shown that SOX2 can act synergistically
with OCT4 in vitro to activate OCT-SOX enhancers and that
SOX2 is necessary for regulating multiple transcription factors
affecting OCT4 expression (Masui et al., 2007). Exactly how
differentiating cells downregulate the transcription factors
controlling self-renewal is unclear. Transcriptional regulation of
NANOG by TGF-b/Activin A and BMP-responsive SMADs
has recently been demonstrated. In undifferentiated hESCs,
SMAD2/3 dominates through TGF-b signaling, whereas
SMAD1/5/8 becomes activated upon BMP-induced differentia-
tion. These SMADs bind the proximal promoter of NANOG with
opposing effects; SMAD2/3 promotes but SMAD1/5/8 inhibits
its expression (Xu et al., 2008). Furthermore, NANOG activity is
regulated posttranslationally by caspase-mediated proteolytic
cleavage, which is associated with differentiation (Fujita et al.,
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tiate, they still self-renew, suggesting that downregulation of
NANOG alone is not sufficient to induce differentiation (Cham-
bers et al., 2007).
Mass spectrometry (MS)-based proteomics is presently the
most powerful tool for dissecting stimulus-dependent dynamics
of phosphorylation events in living cells (Gruhler et al., 2005;
Kratchmarova et al., 2005).We used stable isotope labeling by
amino acids in cell culture (SILAC)-based quantitative MS (Ong
etal., 2002) tostudyearlyphosphorylationanddephosphorylation
events in hESCsuponBMP-induceddifferentiation.Metabolically
labeled hESCs were compared quantitatively with unlabeled
differentiatingcells exposed for various times toBMP.TiO2-based
phosphopeptide enrichment followed byMS identified a large set
of proteins phosphorylated in hESC, including SOX2. Mutational
analysis suggested that phosphorylation of one or more consec-
utiveserine residues inducedSUMOylation. Thisposttranslational
modification (PTM) has been described as inhibiting its transcrip-
tional activity (Tsuruzoe et al., 2006). Using the NetworKIN algo-
rithm (Linding et al., 2007), we linked the phosphorylation sites
to their cognate kinases. This showed that, of the multiple active
kinases, CDK1/2 had the largest number of substrates, including
SOX2. Furthermore, comparison of cells before and after BMP
exposure provided a global map of protein phosphorylation
dynamics as hESCs exit the pluripotent state.
RESULTS
SILAC Analysis of hESCs and the Effect
of BMP-Induced Differentiation





(Figure 1). Rapid differentiation of unlabeled hESCs was induced
by BMP4 addition in the absence of self-renewal growth factors
(Pera et al., 2004); cells were harvested at various times there-
after (Figure 1). Western blot analysis shows that BMP4-induced
differentiation, as previously, resulted in downregulation of OCT4
and SOX2 (Figure S1 available online). Phosphorylation
dynamics were studied using an automated approach to enrich
for phosphopeptides based on SCX and TiO2 (Pinkse et al.,
2008) combined with SILAC technology (Ong et al., 2002) for
accurate relative quantitation. Proteins from undifferentiated
hESCs (0 min) and differentiated cells (30, 60, and 240 min after
BMP4 addition) were extracted, combined, and processed for
quantitative MS analysis (Figure 1). MS intensities of the ‘‘light’’
and ‘‘heavy’’ peaks reflect the relative changes in protein phos-
phorylation between the two samples analyzed. Collectively, the
three SILAC mixtures provided a four-time-point profile of phos-
phorylation events during early differentiation of hESCs
(Figure 1).
The hESC Proteome and Phosphoproteome
From 800,000 spectra collected over 144 LC-MS/MS runs, 5222
proteins were identified with high confidence using a highly
conservative Mascot Score of 35 at the peptide level (false
discovery rate < 1%) (Tables S1 and S2). Because protein abun-
dance cannot be predicted accurately from mRNA levels (Gygi
et al., 1999), these data corroborated protein presence for
many transcripts and additionally demonstrated the existenceof proteins for which there was no direct evidence at the tran-
scriptional level. Of the proteins identified, 1399 (27%) were
phosphorylated on one or multiple residues (Figure S2, Table
S3, and Data Set S1), making these proteome and phosphopro-
teome data sets the largest reported to date for hESCs. In total,
3090 unique phosphopeptides were detected, carrying 3067
phosphorylation sites localized on 2431 serines, 582 threonines,
and 54 tyrosines. These proteome profiles represent a unique
opportunity to gain insights into the functional protein content
and identify active signaling pathways involving these proteins.
The proteins identified were first classified by molecular func-
tion, biological process, and subcellular localization (Figure S3).
The two most abundant categories (molecular function) con-
sisted of nucleic-acid-binding proteins (941 proteins, 18.0%)
and transcription factors (343 proteins, 6.6%), suggesting that
chromatin remodeling, modification, and transcription are highly
active in hESCs. Gene ontology (GO) analyses confirmed enrich-
ment of several GO terms related to these categories in our hESC
proteome (p < 0.001, Hypergeometric test) (Table S4), compared
to the entire human genome. To evaluate whether this overrep-
resentation was specific for pluripotent cells, we also classified
two proteomes previously reported by our group (Van Hoof
et al., 2006), hESCs (HES-2) and their differentiated derivatives
(12 days in the absence of feeder cells) (Figure S4). Interestingly,
we found a reduction (p < 0.05, chi-square test) in the abundance
of transcription factors and nucleic acid binding as ESCs differ-
entiated, indicating that this class of transcriptional and transla-
tional proteins is highly represented in ESCs. Next, we assessed
whether proteins that were identified originated from genomic
regions predicted to be active, as indicated by K4 trimethylation
of histone 3 (H3K4me3), or silent, marked by trimethylation on
K27 (H3K27me3) (Barski et al., 2007; Mikkelsen et al., 2007).
Our proteome notably correlated with whole-genome analysis
of histone 3 methylation in hESCs (Pan et al., 2007), given that
2848 proteins in our catalog carried the activating H3K4me3
mark on their corresponding genes, 279 proteins had both
H3K4me3 and H3K27me3 marks, and 240 proteins had neither
H3K4me3 nor H3K27me3, whereas only 9 were reported as
silenced genes (Figure S5 and Table S5).
Phosphorylation Dynamics during Differentiation
Of the 3090 unique phosphopeptides identified, 1987 were
quantified in at least one of the three SILAC mixtures (Figure S6,
Table S3, and Data Set S1).We achieved a relative standard
deviation (RSD) of 7% (data not shown) by measuring modified
variants of the reported phosphopeptides resulting from trypsin
missed cleavages or methionine oxidations. On this basis, we
found that 1091 phosphopeptides (50% of the quantified phos-
phoproteome) were regulated during differentiation (Table S3
and Data Set S1). Next, we examined the relationship between
peptide abundance and its regulation status (i.e., differentially
regulated or not), applying total peptide count (including multiple
observations of the same peptide within a single experiment).
We observed an inverse correlation between frequency and
regulation status (Figure S6B), indicating that low-abundant
peptides tended to be more regulated than high-abundant
peptides. Thirty minutes after BMP4 addition, the level of phos-
phorylation of 407 proteins was increased, whereas only 25
decreased. Changes of similar magnitude were found atCell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc. 215
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(A) Two populations of hESCs were used, one labeled with SILAC amino acids [13C6,
15N4]-arginine and [
13C6,
15N2]-lysine. Differentiation of unlabeled hESCs was
induced by BMP4, and samples were collected at 30, 60, and 240 min. Differentiated cells and SILAC-labeled hESCs were combined, lysed, and enzymatically
digested.
(B) The threemixtures were subjected to phosphopeptide enrichment based on TiO2 and SCX prior to high-resolution LC-MS/MS analysis. The peak intensities of
the identified phosphopeptides are proportional to their relative abundance.
(C) The three SILAC mixtures provide a profile of phosphorylation events over four time points after the onset of differentiation. Phosphorylation networks were
reconstructed by predicting potential kinases for every phosphosite identified. SUMOylation of the pluripotency transcription factor SOX2 was found to be phos-
phorylation dependent.60 min (506 upregulated, 51 downregulated) and 240 min (622
upregulated, 42 downregulated), suggesting an overall increase
in kinase activity. The time course showed a trend in most of the
phosphopeptide profiles, showing up- or downregulation at
minimally two consecutive time points, suggesting the robust-
ness of the data set. Second, we confirmed phosphorylation216 Cell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc.profiles for GSK3b and 4EIFEBP1 by immunofluorescence and
western blotting, the method of choice being dictated by the
properties of available antibodies (Figure S10).
To gain insight into temporal regulation during differentiation,
phosphopeptides quantified at all time points and significantly
differing in phosphorylation in at least one of the four time points
Cell Stem Cell
Phosphorylation Dynamics in Human Stem CellsFigure 2. Temporal Profiles of Phosphorylation during Differentiation
Changes in phosphorylation levels are shown for those proteins cited in the text.
(A) Specific regulation of four different phosphorylation sites from TP53BP1. S1114 shows a delayed phosphorylation, whereas S500 and S552 belong to inter-
mittent profile. S379 is not regulated during differentiation.
(B) Two phosphopeptides were identified for AP-1 (c-Jun), both of which were transiently phosphorylated.
(C) Y216 from GSK3B shows a sustained phosphorylation profile.
Error bars are shown if the phosphopeptide was quantifiedmore than two times. See Figure S10 for confirmatory western blot and immunofluorescence analyses.were grouped by k-means clustering (Figure S7 and Table S6).
Two phenomena become apparent from these data. First, the
most dramatic phosphorylation changes took place during the
first hour, coincident with SMAD1/5/8 phosphorylation in hESC
(Pera et al., 2004). No phosphopeptides were regulated after
4 hr only, indicating that events are initiated by BMP4 within
this time frame. Second, apart from a small group of dephos-
phorylation events (cluster ‘‘dephosphorylation’’ in Figure S7),
most changes represent an increase in phosphorylation level.
In several cases, the same proteins occupied more than one
cluster, indicating that regulation of phosphorylation is site
specific and that individual sites may be affiliated with different
functions. This is congruent with the idea that proteins can serve
as platforms for integrating signals from various kinases/
cascades (Olsen et al., 2006). One example is tumor suppressor
p53-binding protein 1 (TP53BP1), a hyperphosphorylated tran-
scription activator engaged in the response to DNA damage
(Botuyan et al., 2006), checkpoint signaling during mitosis
(Swiss-Prot by similarity), and hESC differentiation (Pan et al.,
2007). Three phosphopeptides identified for TP53BP1 were
regulated with different kinetics because they belonged to
different profile clusters (delayed and intermittent) (Figure 2
and Table S6).
Signaling Pathways Activated upon BMP-Induced
Differentiation
The coverage of signaling pathways was assessed by projecting
protein identification and quantitative phosphorylation on 130
signaling pathways in Panther (Mi et al., 2007). Components of
nearly all pathways were represented in our data (Figures 3A
and S8), 86 of which contained between 1 and 79 phosphory-
lated proteins. Seventy pathways were represented by proteins
with dynamic phosphorylation (Table S7). This suggests activa-
tion of a protein network composed of multiple signaling
cascades. To investigate this in greater detail, we considered
key components of individual pathways and looked at whetherthe observed phosphorylation sites were those known to be
involved in protein activation. Activation of the BMP pathway
was indicated by phosphorylation of receptor SMADs, SMAD5
and SMAD8 at S465 and S467, respectively, confirming activa-
tion of the BMP4-SMAD-signaling cascade in hESCs (Figures
S9A and S9B) as described previously (Pera et al., 2004).
Several components of PI3K signaling were identified (Figures
3 and S10). Increased phosphorylation of PDPK1 at S241 indi-
cated activation of this kinase for subsequent phosphorylation
of its target AKT1 (PKB). Additionally, an increase in phosphory-
lation of various proteins with confirmed AKT1 target sites was
observed, including S166 of MDM2, S280 of CHK1 (both of
which lead to inhibition of p53-mediated apoptosis), and S341
and S588 of TBC1D4 (also known as AS160). These all point to
activation of AKT1.
c-Jun, which forms the heterodimeric activator protein 1 tran-
scription factor complex with c-Fos, was phosphorylated at S63
and S73, suggesting activation of the JNK pathway. Interest-
ingly, the immediate phosphorylation of c-Jun after differentia-
tion induction at 30 min was followed by a decrease over the
next hours (Figure 2B), indicating that JNK activation was tran-
sient. Wnt signaling is one of the best-covered pathways in our
data set and included multiple proteins with phosphorylation
changes (Figure S9C). Among these was an activating phos-
phorylation at Y216 of GSK3B that was induced within 30 min
of BMP addition (Figure 2C). Phosphorylation of this tyrosine
over time was confirmed in a biological repeat on cell lysates
using western blotting and at the single-cell level using immuno-
fluorescent antibody staining (Figure S10). Furthermore, several
peptides of the key Wnt-signaling protein, b-catenin, were iden-
tified. However, the N-terminal phosphopeptide-marking activity
was not detected, so the activation status of b-catenin could not
be determined from our data directly. However, several coacti-
vators (BCL9, BCL9L, PYGO2) and repressors (TLE1, TLE3)
(Chen and Courey, 2000) of b-catenin were differentially phos-
phorylated at several positions, indicating some level ofCell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc. 217
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IPI Number Gene Symbol (Protein Name) Phosphosites Identified
IPI00002948 LIN28 (Lin-28 homolog A) S3a, S200, T202
IPI00012593 DNMT3B (isoform 1 of DNA (cytosine-5)-methyltransferase 3B) S82a, S136, S202, S209a, T383, S387
IPI00300620 IFITM1 (interferon-induced transmembrane protein 1)
IPI00219089 POU5F1 (isoform A of POU domain, class 5, transcription factor 1; OCT4)
IPI00009703 SOX2 (transcription factor SOX2) S249, S250, S251
IPI00026637 GAL (Galanin precursor) S116a
IPI00020668 UTF (undifferentiated embryonic cell transcription factor 1) S18, T35a, S245a
IPI00007164 FOXD3 (forkhead box protein D3)
IPI00299659 GDF3 (growth/differentiation factor 3 precursor)
IPI00045497 NODAL (nodal homolog precursor)
IPI00299116 PDXL (Podocalyxin-like protein 1 precursor)
IPI00434539 NANOG (isoform 1 of Homeobox protein NANOG)
a These phosphosites were found to be regulated during the differentiation process.regulation of Wnt signaling. Moreover, phosphorylation of casein
kinase I, which phosphorylates b-catenin, was increased on at
least two sites. Combined, these data implied rapid activation
of the Wnt pathway at the onset of BMP-induced differentiation.
Many other phosphorylation events were also observed, but
their effects on the activation of proteins affected are largely
unknown. Nonetheless, their multitude and diversity, as well as
the fact that some of them are shared by several pathways
(e.g., G3BP1 and G3BP2) (Irvine et al., 2004) indicated that
induction of differentiation initiates signaling via an intricate
network that vigorously alters the behavior of hESC.
Additional Effects of Differentiation Induction
To investigate the effects of BMP4-induced differentiation
beyond kinase signaling, proteins with altered phosphorylation
levels (> 0.5-fold, log2 scale) were mapped to GO terms with
respect to molecular function (Table S8) and biological process
(Table S9). These analyses showed the broad range of protein
classes affected by differentiation, indicating that its effects
extended well beyond those proteins participating in established
signal transduction cascades. Some of the processes are related
directly todifferentiation itself (e.g., alterationof cell-cycle kinetics
or cell-cycle exit and initiation of germ layer specification);
however, it was unclear exactly how the individual components
were affected. To address this, the same set of phosphoproteins
was subjected to an unbiased analysis using Anni (Jelier et al.,
2008), an ontology-based interface that applies text mining to
retrieve associations between proteins by co-occurrence in the
literature. This tool classifies proteins by a term or ‘‘concept’’
that they have in common, which is not necessarily a GO term.
Although some of the 39 clusters identified in this manner
(Figure S11 and Table S10) were also defined by GO analysis
(e.g., cell-cycle, cytoskeleton), many additional concepts
emerged, such as transcriptional repression, transcriptional elon-
gation factors, translation initiation factors, and SWI/SNF chro-matin remodeling (Jaenisch and Young, 2008). This implies that
established mechanisms associated with differentiation, like
genome remodeling, silencing of the pluripotency network, and
activation of differentiation-inducing genes, are initiated rapidly
after induction. Additionally, the presence of a protein SUMOyla-
tion cluster indicated active posttranslational processing of
proteins. Furthermore, clusters containing Rab11 family-interact-
ing proteins, microtubule associated proteins, vimentin, GTPase-
activating proteins, tight junction proteins, and focal adhesion
proteins strongly suggested remodeling of the cellular matrix.
Phosphorylation of Pluripotency-Associated Proteins
To determine the phosphorylation status of proteins associated
with pluripotency, wemappedMS identifications to ESC-associ-
ated genes defined by the International Stem Cell Initiative (Ade-
wumi et al., 2007). From the top 20 geneswith aNANOGpairwise
correlation coefficient > 0.5, we detected the protein products of
12, including the three core transcription factors OCT4, SOX2,
and NANOG (Table 1). Sixteen novel phosphosites were identi-
fied in five of these proteins; among these were three residues
of UTF1, three residues of LIN28, seven residues of DNMT3B,
and three consecutive residues of SOX2. During differentiation,
the phosphorylation state changed for six of the sites identified,
suggesting that the ESC-associated proteins to which they
belong are regulated posttranslationally. To find differential
phosphorylation sites of downstream targets for OCT4, SOX2,
and NANOG, we mapped the phosphoproteomes to chromatin
immunoprecipitation data sets published for OCT4, SOX2,
and NANOG (Boyer et al., 2005). Of the 2260 genes reported,
we found 586 products, 100 of which were phosphoproteins
regulated during differentiation, including 19 transcriptional
regulators (Figure 4 and Table S11). Interestingly, these phos-
phorylated proteins are predominantly components of the RNA
posttranscriptional modification (e.g., SFPQ, DDX20, ADAR,
ACIN1, SFRS7) and the gene expression machinery (e.g.,Figure 3. Signaling Pathways Analysis
(A) Nonphosphorylated proteins, nonregulated phosphoproteins, and regulated phosphoproteins were mapped to 130 pathways with Panther classification
system (Mi et al., 2007). Only those pathways with a relative high coverage are shown. The complete analysis can be found in Table S7 and Figure S8.
(B) Graphical representation of PI3K/AKT-signaling pathway. Identified proteins by MS are represented in blue color. Identified phosphosites are also shown
when applicable (red, upregulated site; green, downregulated; gray, not regulated or not quantified). Some examples of other pathways can be found in Figure S9.Cell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc. 219
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Venn diagram representing the overlap of OCT4, SOX2, and NANOG target genes differentially phosphorylated during differentiation. Examples of regulated
phosphosites are shown for every section of the diagram. The full list of proteins can be found in Table S11.POU2F1, SFPQ, PAK1, STAT3, SUMO1, SOX2, HIST1H1).
These results suggested that many components of the hESC
core transcriptional circuitry are regulated by phosphorylation
and that differentiation is accompanied by active modulation of
these processes.
Phosphorylation-Dependent SUMOylation of SOX2
Our MS results showed that SOX2 can be phosphorylated at
three consecutive serine residues: S249, S250, and S251 (Table
S3 and Data Set S1). This serine triplet flanks an upstream
SUMOylation site of SOX2 (Tsuruzoe et al., 2006), the combina-
tion of which resembles the phosphorylation-dependent
SUMOylation motif (PDSM), JKxExxSP, described in other
SOX family members (Hietakangas et al., 2006). We hypothe-
sized that SUMOylation of SOX2 depends on phosphorylation
of one or more of these serine residues in a similar manner. To
address whether crosstalk occurs between these phosphoryla-
tion and SUMOylation sites, a set of SOX2mutants was created,
and their SUMOylation state was investigated using HeLa cells
stably expressing SUMO2 (Vertegaal et al., 2006) (Figures 5,
S12A, and S12B). Expression of WT human SOX2 in these cells
showed a low basal level of SUMOylated SOX2 compared with
free SOX2 (Figures 5 and S12B). However, when the serine resi-220 Cell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc.dues were replaced by aspartic acid (SOX2S249–251D) to mimic
constitutive phosphorylation, high levels of the SUMOylated
SOX2 mutant were observed, including double- and triple-
SUMOylated forms (Figures 5 and S12B). On the other hand,
replacing the serine residues by alanine (SOX2S249–251A) showed
a ratio between the free and SUMOylated form similar to that of
WT SOX2 (Figures 5 and S12B). Furthermore, replacing K245
of the PDSM by alanine (SOX2K245A) completely prevented
SUMOylation of the transcription factor (Figure S12B), indicating
that this lysine residue is the only target for SUMOylation under
these conditions. Notably, none of these mutations affected
the nuclear localization of SOX2 in HUES-7 cells (Figure S12C),
which suggested that phosphorylation of these serine residues
did not initiate immediate export of SOX2 from the nucleus.
The hESC Kinome Network
Consensus motifs of phosphorylation sites are inappropriate
for systematic matching with their corresponding kinases, as
specificity is largely determined by context (Linding et al.,
2007). Linding et al. addressed this issue by developing an algo-
rithm (NetworKIN) that introduces the concept of combining
probabilistic modeled network context with linear motifs recog-
nized by the catalytic domain of kinases (Linding et al., 2007).
Cell Stem Cell
Phosphorylation Dynamics in Human Stem CellsFigure 5. Phosphorylation-Dependent SUMOylation of SOX2
HeLa cells stably expressing His6-SUMO2 (HeLa
SUMO2) were transfected with pCAG expression constructs harboring either GFP (Control), WT Sox2,
Sox2S249–251D, or Sox2S249–251A. Cells were lysed, and His6-SUMO2 conjugates were enriched on nickel-nitrilotriacetic acid-agarose beads. Purified fractions
were subjected to SDS-PAGE and immunoblotted using antibodies to detect Sox2 or SUMO2/3. These results indicate that SUMOylation of SOX2 depends
on phosphorylation at S249–251.Relationships between kinases and all of the phosphorylation
sites defined here were predicted, creating, for the first time,
a kinase-substrate database for hESCs (Table S12). This was
used to create an in vivo kinome for hESCs (Figure 6A),
comprising 107 kinases, representing most of the known kinase
families (Manning et al., 2002). Interestingly, CDK1/2 appeared to
play a prominent role, given that it was predicted to phosphory-
late 1200 peptides in our assay. To investigate this further, all
kinases were predicted for Phospho.ELM (Diella et al., 2004)
and PhosphoSite (http://www.phosphosite.org), two publicly
available repositories of human phosphorylation sites, with
> 23,000 unique phosphosites. By comparing this hypothetical
absolute kinome with the hESC-specific kinome, kinases that
are under- or overrepresented in hESCs, based on the incidence
of specific phosphorylations, could be identified (Figure S13). For
instance, CDK1/2 was found to mediate 26% of the phosphory-
lation events in hESCs, which is significantly more (p < 0.0001,
chi-square test) than the 12% of all theoretical phosphorylation
sites in humans. Additional kinases with activities overrepre-
sented in hESCs were MAPK8, MAPK11, MAPK14, TGFBR2,
GSK3B, and NEK2, the latter being a known modulator of the
cell cycle, just as CDK1/2. Furthermore, CDK1/2, NEK2, and
GSK3B are potential effectors of SOX2 phosphorylation (Table
S12). These findings suggest that prevalent kinases control
cell-cycle processes as well as the activity of pluripotency-asso-ciated transcription factors, both of which are characteristic of
ESCs. The MS data indicated that CDK2 is phosphorylated
progressively at Y15, marking a decrease in its activity (Gu
et al., 1992). Linking site-specific kinases that were found regu-
lated over the investigated time course with their corresponding
upstream kinases generated a temporal kinase-cascade model
that illustrates the dynamics in kinase relationships during differ-
entiation (Figure 6B). This overview suggested that the initial
signal that disturbs the ESC-associated network expands over
time by activating an increasing number of kinases, resembling
the model proposed previously (Miller-Jensen et al., 2007).
DISCUSSION
Self-renewal in pluripotent hESCs is highly sensitive to factors
that trigger differentiation through transmission of signals to
the nucleus. Activation and inactivation of intracellular proteins
by phosphorylation and dephosphorylation are among the
earliest events following binding of a ligand to its receptor. In
addition to regulating protein activity, phosphorylation also
contributes to controlling cell identity by fine-tuning protein
expression. We used MS-based quantitative proteomics here
to monitor dynamic changes in the phosphoproteome of hESCs
at the onset of BMP4-induced differentiation. We probed the
hESC proteome to a depth of 5222 proteins, 586 of which areCell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc. 221
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The NetworKIN algorithm was used to predict kinases for every phosphorylation site identified.
(A) In total, 107 kinases were predicted to regulate the hESC phosphoproteome; the number of substrates is indicated in the pie chart. Kinases predicted to phos-
phorylate < 30 substrates are shown combined in ‘‘others.’’
(B) By linking regulated kinases (blue boxes) to their predicted upstream kinases (red boxes), kinase cascades during hESC differentiation weremodeled. Kinases
regulated at only one time point are depicted as dark blue boxes. This illustrates how a signal spreads over time.thought to be regulated by the core transcriptional network.
Because this core transcriptional network was postulated on
the basis of ChIP data and transcription factor binding does
not necessarily mean that the particular gene is regulated by
that factor, our data set provides high-quality confirmation of
the involvement of many proposed players. GO annotation of
the hESC proteome resulted in prominent subclasses consisting222 Cell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc.of proteins associated with epigenetic modification (Pan et al.,
2007), transcription (Boyer et al., 2005; Efroni et al., 2008), and
translation (Sampath et al., 2008), suggesting that these
processes are prominent in hESCs. Among the 1399 proteins
phosphorylated on a total of 3067 residues, more than 1200 sites
had not been reported previously to our knowledge, 430
belonging to the class of proteins that participate in the core
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implies that the activity of many proteins involved in the pluripo-
tency and self-renewal network is regulated by a selection of
kinases and phosphatases.
Interruption of self-renewal by exogenous factors has major
effects on signaling networks that sustain the undifferentiated
state. Changing the identity of hESC by exposure to extracellular
stimuli is immediately followed by a complete reconstitution of
signaling pathways. This was exemplified by the observation
that half of the phosphoproteome was modulated within the first
hour of BMP4 exposure. In addition to the expected phosphoryla-
tion of receptor SMADs, increased phosphorylation of several
substrates of AKT1 were detected, indicating activation of the
PI3K/AKT pathway. This might have resulted from signaling
through the insulin receptor (Freundetal., 2008), ashESCdifferen-
tiated inmediumcontaining insulin as a survival factor. In addition,
S63 and S73 of c-Jun were phosphorylated, though temporarily,
suggesting transient activity of JNKs. Although crosstalk between
intracellular pathways cannot be deduced from the present data,
there is evidence for reciprocal interactions between JNKs and
AKT. JNKs can phosphorylate AKT1 at T450, thus priming this
protein for activation through phosphorylation by PDK1 (Shao
et al., 2006). Conversely, AKT1 can inhibit the JNK pathway by
phosphorylating ASK1 (MAPKKK5), which lies upstream of
JNKs. This apparent dichotomy is in agreement with our data,
as phosphorylation of c-Jun was early and transient, whereas
phosphorylation of AKT substrates was sustained. This would
tip the balance of proapoptotic (JNKs) and antiapoptotic signaling
(AKT) in favor of the latter.
In addition to changes in signaling pathways, we also found
alterations in established and proposed regulators of pluripo-
tency. For instance, a novel acetylation and three novel phos-
phorylation sites on LIN28 were identified. Ectopic expression
of LIN28 contributes to formation of iPSCs, illustrating the impor-
tance of this pathway in regulating the pluripotent state (Yu et al.,
2007). Furthermore, LIN28 is known to block maturation of
primary pri-Let-7g transcripts to mature Let-7g transcripts (Vis-
wanathan et al., 2008). This led to the hypothesis that Let-7
and LIN28 participate in an incoherent feed-forward loop that
contributes to rapid differentiation (Marson et al., 2008). Another
example is the detection of three novel phosphorylation sites on
the transcription factor UTF1, a chromatin-associated transcrip-
tional repressor crucial for differentiation of mESCs (van den
Boom et al., 2007); two of the phosphorylation sites were regu-
lated upon differentiation. For DNMT3B, six novel phosphoryla-
tion sites were identified, two of which were regulated. Upon
differentiation, methyltransferases DNMT3A and DNMT3B are
recruited to the OCT4 promoter, thereby repressing its transcrip-
tion through CpG methylation (Feldman et al., 2006). We also
identified three novel consecutive phosphosites on SOX2, which
we investigated in more depth.
The transcription factor SOX2 is one of the three core tran-
scription factors that play essential roles in embryonic develop-
ment (Avilion et al., 2003; Yuan et al., 1995) and self-renewal of
ESCs (Fong et al., 2008; Masui et al., 2007). However, little is
knownabout how the activity of SOX2 itself is regulated.Whereas
SUMO conjugation was found to inhibit binding of mouse SOX2
to DNA (Tsuruzoe et al., 2006), the PDSM defined initially in
SOX3, SOX8, and SOX9, among other transcriptional regulators,had not been identified in SOX2 (Hietakangas et al., 2006). This
can be explained by a surplus residue between E247 and S251,
which does not match the established consensus sequence
(Hietakangas et al., 2006). Combined, our findings indicated
that the consensus of this PDSM is rather flexible and suggested
that the three adjacent serine residues immediately upstream of
P252 have redundant functions. Moreover, they imply that tran-
scriptional activity of SOX2 is regulated by SUMOylation that
results from phosphorylation. Interestingly, all phosphorylated
forms of SOX2 were identified in hESCs, but none increased
significantly upon differentiation, suggesting that transcriptional
activity of SOX2 is controlled stringently both in differentiating
and undifferentiated ESCs. A critical level of functional SOX2,
essential for self-renewal (Chew et al., 2005; Kopp et al., 2008),
is probably maintained by a fine balance between de novo
synthesis, PTMs that alter its activity, and translocation from
the nucleus followed by degradation. Of note is that all SOX2
mutants were localized predominantly in the nuclei of HUES-7
transfectants. This implies that phosphorylation of SOX2, as
mimicked by the S249-251D mutation, and the consequent
SUMOylation at K245donot immediately lead tomassivenuclear
export and subsequent targeting for degradation. Presumably,
the SUMOylation pathway is saturated when SOX2 is overex-
pressed in HUES-7 cells, requiring concomitant overexpression
of SUMO in order to detect SUMOylated forms of SOX2, as
observed for SUMO2-overexpressing HeLa cells. Further inves-
tigation is needed to determine the balance between de novo
synthesis and degradation of SOX2 and the role of PTMs therein.
Using the NetworKIN algorithm to predict the kinases respon-
sible for phosphorylation during differentiation, we recon-
structed a hESC kinome composed of 107 kinases, 26 of which
were regulated by phosphorylation upon induction of differentia-
tion. Because of their low abundance, only 54 phosphotyrosine
peptides were identified; consequently, receptor Tyr kinases
(e.g., INSR, EPHA4, and IGFIR) seem underrepresented. In
contrast, 2431 phosphoserine peptides were identified, pointing
to a central role for CDK1/2. In addition to CDK1/2 and GSK3B,
MAPK8 (a JNK protein), as well as MAPK11 and MAPK14 (p38
MAPK proteins) of the CMGC Ser/Thr protein kinase family
(Manning et al., 2002), have well-documented functions in differ-
entiation. p38 MAPKs are inhibitory during cell commitment and
are antiapoptotic during late stages of differentiation, whereas
the proapoptotic JNKs are involved in ectoderm and primitive
endoderm differentiation (Binetruy et al., 2007). However, protein
phosphorylation is regulated by a precise control of protein
kinase (PK) and protein phosphatase (PP) activities. PPs are
regulated, in the same way as kinases, by an array of targeting
and regulatory subunits, PTMs, and by specific inhibitors. A total
of 43 PPs (30% of all phosphatases reported in SwissProt) were
identified in our data set; four of them presented differentially
regulated phosphosites: PPMH1 (Ser/Thr PPs), DUSP19 (dual
specificity PPs), and PTPN13 and PTPN14 (Tyr PPs). PKs, as
well as PPs, possess basal activities; therefore, it should be
noted that some of the upregulated phosphopeptides in our
study could result from inhibition of their specific PPs, rather
than from an increase of the kinase activity. The same applies
for downregulated phosphopeptides.
It is not surprising that most dynamic phosphorylation of
signaling cascade components occurred within 30 min ofCell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc. 223
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others studying EGF stimulation in HeLa cells (Olsen et al., 2006).
The multiplicity of components of the network in hESCs and their
initiation upon differentiation are far too complex to be covered in
entirety here. Nevertheless, the multitude and variety of proteins
that undergo phosphorylation changes during the first hours of
differentiation suggest rapid and dramatic reorganization of the
proteome that extends far beyond signaling alone. Proteins
affected were classified based on GO annotation and contextual
co-occurrence in literature. These included methylation, tran-
scription initiation, and transcriptional elongation, indicating
that silent developmental genes controlled by OCT4, SOX2,
and NANOG experience complex transcriptional regulation
(Guenther et al., 2007). These genes are occupied by nucleo-
somes with histone H3K4me3 and histone H3K27me3. Although
transcription is initiated, there is no productive elongation
because of repression byPcGproteins (Azuara et al., 2006; Bern-
stein et al., 2006). Transcriptional repression of ESC-associated
genes and SWI/SNF chromatin remodeling are also concepts
associated with differentiation. Furthermore, the emergence of
a protein SUMOylation cluster (consisting of E3 ligases, hydro-
lase, and SUMO-isopeptidase) suggests that this type of PTM
is a concept linked to differentiation that extends beyond the
effects on SOX2 described above. Finally, the presence of clus-
ters containing Rab11 family-interacting proteins, microtubule-
associated proteins, vimentin, GTPase-activating proteins, tight
junction proteins, and focal adhesion proteins suggested that
initiation of differentiation leads to remodeling of cell shape. We
had shown previously that hESCs grown as monolayer cultures
under feeder-free conditions (i.e., identical to those used in this
study) havean epithelial phenotype, evidencedby the expression
of proteins belonging to adherence junctions, tight junctions, gap
junctions, and desmosomes (VanHoof et al., 2008). The observa-
tion that proteins forming these structures undergo increased
phosphorylation strongly suggests that their biogenesis changes
(Eckert and Fleming, 2008) during a process that is initiated at the
onset of differentiation.
Conclusions
In addition to an extensive profile of the hESC proteome, our
approach generated a dynamic map of protein phosphorylation
during differentiation of hESC showing concordance over time,
which we used to define a wide spectrum of novel kinase
substrates. These data provide a rich resource for further inves-
tigation of the function of individual proteins, as exemplified by
the phosphorylation sites of SOX2 that regulate its transcrip-
tional activity through SUMOylation. Linking genomic, epige-
nomic, transcriptomic, and proteomic approaches will improve
our knowledge of stem cell biology and (human) development
and, thereby, our ability to control self-renewal versus differenti-
ation fate decisions by pluripotent cells.
EXPERIMENTAL PROCEDURES
SILAC Labeling of hESCs and Differentiation
HUES-7 hESCs were cultured, as previously (Braam et al., 2008), on Matrigel
without MEFs and differentiation induced by 50 ng/ml of BMP4. For details,
see Supplemental Experimental Procedures.224 Cell Stem Cell 5, 214–226, August 7, 2009 ª2009 Elsevier Inc.Western Blotting
Western blotting was carried out as previously (Van Hoof et al., 2006). For
details, see Supplemental Experimental Procedures.
Phosphopeptide Enrichment and Mass Spectrometric Analysis
Protein (1 mg) was first reduced/alkylated and digested with Lys-C. The
mixture was then diluted 4-fold to 2 M urea and digested further with trypsin.
Strong cation exchange was performed as before (Pinkse et al., 2008); 24 frac-
tions (1 min each, i.e., 50 ml elution volume) were collected by hand. The online
TiO2 chromatography was set using a triple stage precolumn, and both TiO2
eluate and flowthrough fractions were chromatographically resolved using a
100 min linear gradient in the analytical column. The LTQ-Orbitrap was oper-
ated in data-dependent mode, automatically switching between MS and
MS/MS. Full-scan MS spectra (m/z 400–1500) were acquired in the Orbitrap
with a resolution of 60,000, and the two most intense ions were selected for
MS/MS fragmentation in the linear ion trap. Further details can be found in
the Supplemental Experimental Procedures.
Peptide Identification and Quantitative Analysis
Raw data were converted to single DTA files using Bioworks 3.2 and merged
into Mascot Generic Format files, which were searched using an in-house
licensedMascot v2.2 search engine against IPI human 3.28 database (contain-
ing 68,020 sequences). Carbamidomethyl cysteine was set as fixed modifica-
tion; protein N-acetylation, oxidized methionines, serine, threonine and
tyrosine phosphorylation, deamidation, and SILAC-labels ([13C6,
15N4]-arginine
and [13C6,
15N2]-lysine) were set as variable modifications. The mass tolerance
of the precursor ion was 10 ppm and 0.9 Da for fragment ions. The false
discovery rate was determined as < 1% (Mascot score threshold of 35) using
the decoy database approach. MSQuant (http://msquant.sourceforge.net)
was used to quantitate the levels of the identified phosphopeptides and deter-
mine the exact phosphorylation site within the peptide (Olsen et al., 2006).
Every phosphopeptide quantitation was manually validated; peptides with
low signal/noise ratios, low number of MS scans, or overlapping peaks were
not included for quantitative purposes. StatQuant, an in-house-developed
Java software, was used to correct for the arginine-to-proline conversion
artifacts (Van Hoof et al., 2007), statistical analysis, comparison, and normal-
ization.
Construction of Human SOX2 Mutants
Wild-type human SOX2 was amplified by PCR using 50-GGAATTCTCGGC
GGCCGCCGGCGG-30 in combination with 50-GGAATTCTCACAGATCCTC
TTCTGAGATGAGTTTTTGTTCCATGTGTGAGAGGGGCAGTGTGC-30 (EcoRI
site, underlined; myc-tag sequence, italicized) and pcDNA3.1/Zeo-hSOX2
(a gift from Dr. N.A. Hanley) as template. The myc-tagged human SOX2 PCR
fragment was ligated into pGEM-T and sequenced to check for errors.
Mutations were introduced by digestion of this pGEM-hSOX2-myc plasmid
with BplI, followed by ligation of synthetic double-stranded oligos, outlined
in Table S13, and sequencing to verify the mutations. Each human SOX2
construct was isolated from the different pGEM-hSOX2-myc variants by
digestion with EcoRI and was ligated into pCAG-GFP-IRES-Puror (Braam
et al., 2008) linearized using EcoRI, thus replacing the existing GFP open
reading frame. The resulting pCAG-hSOX2-myc mutants were sequenced to
confirm correct orientation behind the pCAG promoter.
Transfection and Immunofluorescent Analysis of HUES-7 Cells
HUES-7 cells were transfected as described previously (Braam et al., 2008)
with the pCAG-hSOX2-myc variants and fixed after 48 hr. Fixed cells were
stained using specific antibodies. For details, see Supplemental Experimental
Procedures.
Culture and Transfection of HeLa Cells and Purification
of His6-SUMO2-Conjugated Proteins
HeLa cells, stably expressing His6-SUMO2 were cultured as described previ-
ously (Vertegaal et al., 2004), and transfected with the pCAG-hSOX2-myc
variants using polyethyleneimine. The following day, cells were lysed and
His6-SUMO2 conjugates purified on nickel-nitrilotriacetic acid-agarose beads
(QIAGEN) as described previously (Schimmel et al., 2008).
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Supplemental Data include Supplemental Experimental Procedures, 13
figures, 13 tables, and 1 data set and can be found with this article online at
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